MAP2K7 and esophageal cancer: To further confirm that inhibition of AKT/mTOR and MEK/ERK contribute to esophageal cancer cell migration, we applied the ERK inhibitor U0126 and the AKT inhibitor LY294002 to Eca109 cells and measure their effect using wound healing assay.